🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)The sulfur burps are KILLING me someone help

The sulfur burps are KILLING me someone help

NauseaFreeNow Thu, Apr 9, 2026 at 8:14 AM 27 replies 1,164 viewsPage 1 of 6
NauseaFreeNow
Member
345
1,234
Aug 2024
Indiana
Apr 9, 2026 at 8:14 AM#1

Nausea arrived on day two of each dose step, lasted about four days, and disappeared entirely by the second week — until the step where it did not.

The question I want answered is what distinguishes the nausea you can titrate through from the nausea that means stop.

Tell me what I have not thought of.

39 9stefan_berlin, Dr.EM_Chicago, pete_RVA and 36 others
Reply Quote Save Share Report
BenResearch_OR
Senior Member
2,456
11,234
Dec 2023
Oregon
Apr 9, 2026 at 8:19 AM#2

Short answer first, then the reasoning. The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the fat fraction of meals in the two days after dosing, and do not lie down straight after eating. Most of what people call unmanageable nausea is a meal-size and meal-composition problem interacting with a stomach that is emptying slowly.

38 8PharmD_Rodriguez, julia.endo, JessicaM_2024 and 35 others
Reply Quote Save Share Report
LondonLisa
Member
912
3,456
Mar 2024
London, UK
Apr 9, 2026 at 8:25 AM#3
BenResearch_OR said:
The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the…

Agreed on adaptation, with a caveat: adaptation applies to gastric emptying and not to everything. If your problem is the aversion rather than the fullness, waiting does less, because the aversion is central and it is the mechanism working as intended.

37 7RetaRick_CA, JenPlateau, SallyK_inj and 34 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
mark_tokyo
Member
456
1,890
Jun 2024
Tokyo, JP
Apr 9, 2026 at 8:30 AM#4
NauseaFreeNow said:
Nausea arrived on day two of each dose step, lasted about four days, and disappeared entirely by the second week — until the step where it did not.

Can confirm the pattern NauseaFreeNow describes. Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts. Receptor-level tachyphylaxis to the delayed-emptying effect develops over weeks while the central appetite effect persists, so the same dose is materially more comfortable at week six than at week two. A slower ladder therefore reaches the same dose with less cumulative nausea, not the same nausea spread thinner.

36 6HPLC_Greg, LibrarianMeg, bri_stats and 33 others
Reply Quote Save Share Report
sophie_paris
Member
212
890
Nov 2024
Paris, FR
Apr 9, 2026 at 8:59 AM#5

Adding the clinical framing, because it changes how the question reads. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

35 5BethLabQueen, ChrisMacros, KetoKyle and 32 others
Reply Quote Save Share Report
1236

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register